Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions

Microscopy Research and Technique
Kazuo KitamuraT Eto

Abstract

We discovered adrenomedullin (AM) from human pheochromocytoma tissue by monitoring the elevating activity of intracellular cyclic AMP (cAMP) in rat platelets in 1993. Since the discovery of AM, it has attracted intense interest from cardiovascular researchers because AM elicits multiple biological activities, including a potent and powerful hypotensive activity caused by dilatation of resistance vessels. AM is biosynthesized and secreted from tissues, including cardiovascular organs. In addition to AM, "proadrenomedullin N-terminal 20 peptide (PAMP)," another biologically active peptide, was found to be processed from the AM precursor. Plasma AM levels are increased in various cardiovascular and renal diseases. AM, therefore, seems to function as a novel system that controls circulation and body fluid, and may be involved in pathophysiological changes in cardiovascular diseases. Therefore, in this review we will focus on the structure of AM and its gene, distribution, receptor, and the physiological and pathological roles of AM in cardiovascular disease.

References

May 29, 1992·Biochemical and Biophysical Research Communications·K KitamuraT Eto
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J S FinkR H Goodman
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G J CooperK B Reid
Oct 13, 1995·Biochemical and Biophysical Research Communications·H ShojiH Matsuo
Oct 27, 1995·The Journal of Biological Chemistry·S KapasA J Clark
Nov 15, 1995·Journal of the American College of Cardiology·T NishikimiH Matsuoka
Apr 28, 1995·European Journal of Pharmacology·J KatoT Eto
Apr 1, 1995·Histochemistry and Cell Biology·H WashimineT Eto
Jul 30, 1993·Biochemical and Biophysical Research Communications·K KitamuraT Eto
Sep 15, 1993·Biochemical and Biophysical Research Communications·J SakataT Eto
Feb 6, 1995·European Journal of Pharmacology·H HeY Abe
Jun 15, 1995·Biochemical and Biophysical Research Communications·K KuwasakoT Eto
Sep 22, 1994·European Journal of Pharmacology·T EbaraH Iwao
Jun 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A J BeanT Hökfelt
Jun 30, 1994·Biochemical and Biophysical Research Communications·S SugoH Matsuo
Aug 30, 1994·Biochemical and Biophysical Research Communications·T IshimitsuH Matsuo
Mar 21, 1994·FEBS Letters·K KitamuraT Eto
Oct 15, 1993·Biochemical and Biophysical Research Communications·C NukiA Wada
Apr 30, 1993·Biochemical and Biophysical Research Communications·K KitamuraT Eto
Dec 5, 1995·Biochemical and Biophysical Research Communications·A Sato, D J Autelitano
Dec 26, 1995·Biochemical and Biophysical Research Communications·S Kapas, A J Clark
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·A E LuebkeI M Dickerson

❮ Previous
Next ❯

Citations

Jul 3, 2010·Journal of Molecular Neuroscience : MN·Kazuhiro TakahashiKazuhito Totsune
Nov 19, 2003·Biochemical and Biophysical Research Communications·Maho OgoshiYoshio Takei
Apr 2, 2003·Regulatory Peptides·Tanenao EtoKazuo Kitamura
Apr 2, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mariko Harada-ShibaKazunori Kataoka
Jun 11, 2005·American Journal of Respiratory and Critical Care Medicine·Shinsuke MurakamiHiroshi Kimura
Mar 13, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hiroki KuriharaTomoyuki Kuwaki
Feb 10, 2010·Zoological Science·Tsuyoshi KawadaHonoo Satake
Nov 4, 2004·Biochemical and Biophysical Research Communications·Toshihiro TsurudaTanenao Eto
Jul 21, 2009·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Marty K S Wong, Yoshio Takei
Jul 28, 2009·Heart Failure Clinics·Rahul Kakkar, Richard T Lee
Feb 3, 2007·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Mukaddes EşrefogluMuhittin Yürekli
Apr 15, 2015·Peptides·Kazuhiro TakahashiKiriko Kaneko
Jan 27, 2005·Pharmacology & Therapeutics·Shabaz A Hamid, Gary F Baxter
Jul 7, 2015·European Journal of Pharmacology·Johji Kato, Kazuo Kitamura
Jun 5, 2004·Regulatory Peptides·Jens F RehfeldAnders H Johnsen
Jul 31, 2007·Journal of the American College of Surgeons·Amit J DwivediPing Wang
May 7, 2016·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Johannes Tobias NeumannKarsten Sydow
Feb 22, 2017·International Journal of Molecular Sciences·Nicola Principi, Susanna Esposito
Apr 28, 2017·Drug Development Research·Sayaka NagataKazuo Kitamura
Jan 1, 2012·JRSM Cardiovascular Disease·Hoi Kin WongBernard M Y Cheung
Feb 8, 2018·World Journal of Pediatrics : WJP·Kotb Abbass MetwalleyTahra Sherief
Feb 22, 2017·Journal of Burn Care & Research : Official Publication of the American Burn Association·Jochen GilleArmin Sablotzki
Mar 31, 2018·Molecular Neurobiology·Hilda FerreroMaría J Ramírez
Nov 13, 2003·British Journal of Cancer·M K OehlerR Bicknell
Feb 6, 2017·Journal of Human Kinetics·Krzysztof Krzeminski
Sep 6, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Johji KatoTanenao Eto
Jan 7, 2017·Circulation Research·Mark R Thomas, Gregory Y H Lip
Nov 21, 2018·Critical Reviews in Clinical Laboratory Sciences·Magnus Nakrem LyngbakkenTorbjørn Omland
Mar 22, 2019·Journal of Biochemistry·Sayaka NagataKazuo Kitamura
Jun 16, 2006·The Journal of Pharmacology and Experimental Therapeutics·Matlubur RahmanMasakazu Kohno
Aug 5, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Won KimSung Kwang Park

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.